Chitosan-Coated Solid Lipid Nano-Encapsulation Improves the Therapeutic Antiairway Inflammation Effect of Berberine against COPD in Cigarette Smoke-Exposed Rats

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr class="thead"><td class="align_left"> </td><td class="align_center">Total leukocyte (×10<sup>5</sup> cells/mL)</td><td class="align_center">Macrophage (×10<sup>5</sup> cells/mL)</td><td class="align_center">Neutrophils (×10<sup>5</sup> cells/mL)</td></tr><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr><td class="align_left">Control group</td><td class="align_center">2.46 ± 0.32</td><td class="align_center">1.62 ± 0.2</td><td class="align_center">0.19 ± 0.1</td></tr><tr><td class="align_left">CS group</td><td class="align_center">19.4 ± 5.1</td><td class="align_center">8.9 ± 1.4</td><td class="align_center">6.9 ± 1.6</td></tr><tr><td class="align_left">Ber + CS group</td><td class="align_center">11.2 ± 1.3</td><td class="align_center">5.9 ± 1.2</td><td class="align_center">4.1 ± 0.6</td></tr><tr><td class="align_left">NanoBer + CS group</td><td class="align_center">6 ± 1.1</td><td class="align_center">3 ± 0.9</td><td class="align_center">2.23 ± 0.7</td></tr><tr class="table-tr"><td colspan="4"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td><div>Data represent mean ± SD.<br/></div></td></tr></table>

<div>Inflammatory cell counts in BALF.</div>

Canadian Respiratory Journal

tab3

Table 3

Table 3: Chitosan-Coated Solid Lipid Nano-Encapsulation Improves the Therapeutic Antiairway Inflammation Effect of Berberine against COPD in Cigarette Smoke-Exposed Rats 

Table 3 | Chitosan-Coated Solid Lipid Nano-Encapsulation Improves the Therapeutic Antiairway Inflammation Effect of Berberine against COPD in Cigarette Smoke-Exposed Rats 